Treatment of relapsed blast-phase Philadelphia-chromosome-positive leukaemia after non-myeloablative stem-cell transplantation with donor lymphocytes and imatinib.

Bipin N Savani Ramaprasad Srinivasan Igor Espinoza-Delgado Colleen Dorrance Yoshiyuki Takahashi Takehito Igarashi Katayoun Rezvani Andreas Lundqvist A John Barrett Richard W Childs

Lancet Oncol

Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Building 10, Hatfield CRC, Room 3-5330, 10 Center Drive MSC 1202, Bethesda, MD 20892-1202, USA.

Published: October 2005

Download full-text PDF	Source
http://dx.doi.org/10.1016/S1470-2045(05)70391-0	DOI Listing

Publication Analysis

Top Keywords

treatment relapsed

relapsed blast-phase

blast-phase philadelphia-chromosome-positive

philadelphia-chromosome-positive leukaemia

leukaemia non-myeloablative

non-myeloablative stem-cell

stem-cell transplantation

transplantation donor

donor lymphocytes

lymphocytes imatinib

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!